Clinical development strategy

IMMUNO-ONCOLOGY INSIGHTS

Clinical development strategy

October 2020
Clinical development strategy

Foreword

Immuno-Oncology Insights - Spotlight on clinical development strategy

Immuno-Oncology Insights - Spotlight on clinical development strategy

Jon Wigginton
9 September 2020
Read

Expert Insight

Clinical development strategy of immunotherapy combination

Clinical development strategy of immunotherapy combination

Tomohiro Enokida, Caitlin Carr, Nina Bhardwaj
10 December 2020
Read

Commentary

The concept of ‘iatrogenic resistance’: insights into mechanisms of induction of resistance to immune checkpoint blockade in combination immunotherapy

The concept of ‘iatrogenic resistance’: insights into mechanisms of induction of resistance to immune checkpoint blockade in combination immunotherapy

Seema Gupta, Samir Khleif
8 October 2020
Read
Cancer Immunotherapy 2020: Opportunities and Challenges on the Road Ahead

Cancer Immunotherapy 2020: Opportunities and Challenges on the Road Ahead

Jon Wigginton
8 October 2020
Read

Interview

Finding the white space: a multi-stakeholder approach to accelerating combination drug development

Finding the white space: a multi-stakeholder approach to accelerating combination drug development

Jill O'Donnell-Tormey
18 September 2020
Read
How will the rapidly developing I-O combination therapy picture continue to evolve?

How will the rapidly developing I-O combination therapy picture continue to evolve?

16 September 2020
Read
Analyzing current trends and future directions in I-O clinical development

Analyzing current trends and future directions in I-O clinical development

Daina Graybosch
14 September 2020
Read
Leveraging advances in biological understanding to inform combination decision-making

Leveraging advances in biological understanding to inform combination decision-making

Michael Quigley
10 September 2020
Read

Podcast

Analyzing current trends and future directions in I-O clinical development - Podcast

Analyzing current trends and future directions in I-O clinical development - Podcast

Daina Graybosch
8 October 2020
Listen

Expert Roundtable Video

Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?

Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?

J J Luke, J Fairchild , R Taylor et al.
8 October 2020
Watch

Expert Roundtable

Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?

Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?

J J Luke, J Fairchild , R Taylor et al.
11 November 2020
Read